Connect with us

Hi, what are you looking for?

Saturday, May 31, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "Innovent Biologics"

Innovent Biologics secures 2nd NDA approval for lung cancer drug as 1st-line treatment

Innovent Biologics secures 2nd NDA approval for lung cancer drug as 1st-line treatment

Medical and Pharmaceutical

Innovent Biologics secures 2nd NDA approval for lung cancer drug as 1st-line treatment

China's National Medical Products Administration approved the initial new drug application in January

Rowan DunneApril 25, 2025

Innovent and ASK Pharm scoop Chinese regulator approval for oral lung cancer drug

Innovent and ASK Pharm scoop Chinese regulator approval for oral lung cancer drug

Medical and Pharmaceutical

Innovent and ASK Pharm scoop Chinese regulator approval for oral lung cancer drug

'Limertinib' targets non-small cell lung cancer with a particular mutation that is prevalent in Asian patients

Rowan DunneJanuary 17, 2025

Roche secures rights to Chinese biotech company's small cell lung cancer drug

Roche secures rights to Chinese biotech company's small cell lung cancer drug

Medical and Pharmaceutical

Roche secures rights to Chinese biotech company’s small cell lung cancer drug

Innovent Biologics will receive up to US$1 billion in milestone payments and royalties

Rowan DunneJanuary 3, 2025

More Posts